New drug shows promise for Long-Term relief of severe itching
Symptom relief
Ongoing
This study looks at the long-term safety of nemolizumab in 500 adults with prurigo nodularis, a skin condition causing intense itching and nodules. Participants had already taken nemolizumab in earlier studies. The main goal is to track side effects over up to 184 weeks, while al…
Phase: PHASE3 • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated May 07, 2026 18:38 UTC